These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 3097413)
41. [Congenital adrenal hyperplasia: 3 clinical forms in one family]. Youlton R Rev Med Chil; 1985 Dec; 113(12):1217-21. PubMed ID: 2942997 [No Abstract] [Full Text] [Related]
42. Rapid diagnosis of congenital adrenal hyperplasia by high performance liquid chromatography. Weisman Y; Bar A; Root A; Spirer Z; Golander A Clin Chim Acta; 1984 Mar; 138(1):1-8. PubMed ID: 6609026 [TBL] [Abstract][Full Text] [Related]
43. [Determination of 17-hydroxyprogesterone levels in the treatment of children with the adrenogenital syndrome]. Vavrinec J; Dvorák P; Zizkovský V; Kopecký A; Pospísilová D; Starý J Cesk Pediatr; 1983 Sep; 38(9):533-6. PubMed ID: 6315246 [No Abstract] [Full Text] [Related]
44. 125I radioimmunoassay for 17 alpha-hydroxyprogesterone in plasma, for diagnosing and managing congenital adrenal hyperplasia. Yeo KH; Whitau WJ Clin Chem; 1985 Mar; 31(3):454-6. PubMed ID: 3971567 [TBL] [Abstract][Full Text] [Related]
45. Radioimmunoassay of blood-spot 17 alpha-hydroxyprogesterone in the management of congenital adrenal hyperplasia. Robinson JA; Dyas J; Hughes IA; Riad-Fahmy D Ann Clin Biochem; 1987 Jan; 24 ( Pt 1)():58-65. PubMed ID: 3827186 [TBL] [Abstract][Full Text] [Related]
51. Neonatal screening for congenital adrenal hyperplasia in North-Eastern Italy: a report three years into the program. Cavarzere P; Camilot M; Teofoli F; Tatò L Horm Res; 2005; 63(4):180-6. PubMed ID: 15818055 [TBL] [Abstract][Full Text] [Related]
52. Response to treatment of congenital adrenal hyperplasia in infancy. Young MC; Hughes IA Arch Dis Child; 1990 Apr; 65(4):441-4. PubMed ID: 2346339 [TBL] [Abstract][Full Text] [Related]
53. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling. Jiang X; Tang F; Feng Y; Li B; Jia X; Tang C; Liu S; Huang Y J Pediatr Endocrinol Metab; 2019 Nov; 32(11):1253-1258. PubMed ID: 31603856 [TBL] [Abstract][Full Text] [Related]
54. Age of appearance of circadian rhythm in blood 17-hydroxyprogesterone in 21-hydroxylase deficiency. Sólyom J Acta Physiol Hung; 1991; 78(2):107-10. PubMed ID: 1808976 [TBL] [Abstract][Full Text] [Related]
55. Serum 3 alpha-androstanediol glucuronide measurements in children with congenital adrenal hyperplasia. Hatun S; Yordam N; Calikoğlu AS Eur J Endocrinol; 1994 Nov; 131(5):504-8. PubMed ID: 7952161 [TBL] [Abstract][Full Text] [Related]
56. Plasma 17 alpha-hydroxyprogesterone and aldosterone concentrations in infants and children with congenital adrenal hyperplasia--the role of salt-losing hormones in salt wasting. Holcombe JH; Keenan BS; Clayton GW J Pediatr; 1981 Apr; 98(4):573-5. PubMed ID: 7205484 [No Abstract] [Full Text] [Related]
57. Untreated congenital adrenal hyperplasia presenting with severe androgenic alopecia. O'Driscoll JB; Anderson DC J R Soc Med; 1993 Apr; 86(4):229. PubMed ID: 8505734 [No Abstract] [Full Text] [Related]